Alprazolam Calox

Quick links

Choose a section

Quick links to important sections

Advertisements
Advertisements

Overview of Alprazolam Calox

Alprazolam Calox

Alprazolam Calox is a pharmaceutical formulation containing alprazolam, a chemical compound belonging to the benzodiazepine class. This medication is primarily utilized for its effects on the central nervous system to address specific psychological and physiological conditions characterized by excessive neural activity.

Classification and Mechanism

As a benzodiazepine, alprazolam works by modulating the activity of gamma-aminobutyric acid (GABA) receptors in the brain. GABA is an inhibitory neurotransmitter responsible for reducing the excitability of neurons. By enhancing the efficiency of GABA, the medication promotes a calming effect on the nervous system, which helps in managing states of heightened agitation or emotional distress.

Primary Uses

Alprazolam Calox is typically indicated for the management of various conditions related to clinical anxiety and panic. Its applications include:

  • Anxiety Disorders: Treatment of generalized anxiety symptoms, including persistent tension, apprehension, and irritability.
  • Panic Disorder: Management of panic attacks, which are sudden episodes of intense fear accompanied by physical symptoms such as palpitations or shortness of breath.
  • Anxiety Associated with Depression: Addressing anxiety symptoms that occur concurrently with depressive states.

Therapeutic Intent

The primary goal of Alprazolam Calox is to provide short-term symptomatic relief. It is designed to stabilize brain activity during periods of acute distress, allowing for improved daily functioning in individuals experiencing debilitating levels of anxiety or panic-related symptoms.

Regulatory References

  1. WHO Essential Medicines List: Benzodiazepines
Advertisements

What side effects are possible with Alprazolam Calox?

Possible side effects and safety information

The safety profile of Alprazolam is formally organized by regulatory authorities, with most reported adverse reactions being linked to the nervous system and psychiatric domain, consistent with its classification as a Central Nervous System (CNS) depressant. The official safety information classifies these effects based on their documented occurrence rate.

Frequency-Classified Adverse Reactions

Classification Examples of Documented Effects
Very Common (ge 1/10) Sedation, Drowsiness.
Common (ge 1/100 to <1/10) Depression, Ataxia (impaired coordination), Memory impairment, Headache, Fatigue, Changes in Appetite or Weight, Constipation.
Uncommon (ge 1/1,000 to <1/100) Amnesia, Tremor, Hostility, Aggression, Sexual dysfunction.
Not Known Paradoxical reactions (e.g., agitation), Serious skin reactions, Jaundice, Hepatic failure.

Serious Safety Considerations

Regulatory documents emphasize the risk of physical and psychological dependence, which increases with the dose and duration of exposure. This may lead to a severe withdrawal syndrome upon abrupt cessation. The label also notes the potential for Respiratory Depression, a critical concern, particularly when the medicine is used alongside opioid medications. Other serious documented risks include the possibility of Anterograde Amnesia and rare occurrences of severe Hepatotoxicity.

Population-Specific Safety Notes

The official labeling includes specific cautions for certain populations. Older adults are noted to have a heightened risk of dose-related adverse effects, specifically sedation and ataxia, which increases the potential for falls. Caution is also advised for patients with severe hepatic impairment or severe respiratory insufficiency.

Advertisements

Overdose and Emergency Response

Overdose Manifestations

Overdose of Alprazolam Calox typically presents as an extreme exaggeration of its Central Nervous System (CNS) depressant effects. Documented manifestations from regulatory sources include severe drowsiness (somnolence), mental confusion, slurred speech, impaired coordination (ataxia), and muscle weakness. These symptoms reflect the established CNS depression spectrum.

Severe Outcomes and Mandated Emergency Action

Life-threatening outcomes such as profound sedation, respiratory depression, coma, and death are officially documented, particularly when Alprazolam is co-ingested with other CNS depressants like alcohol or opioid medicines.

Immediate medical attention must be sought if an overdose is suspected. Urgent professional help is explicitly required if signs include slow breathing with long pauses, blue-colored lips, or if the individual is hard to wake up.

Management is primarily based on symptomatic and supportive treatment and continuous monitoring of vital signs. The specific benzodiazepine antagonist, Flumazenil, is generally reserved for selective hospital use due to documented risks. Elderly patients and those with hepatic impairment may be more susceptible to experiencing elevated effects.

Advertisements

Therapeutic Uses of Alprazolam Calox

Alprazolam Calox is commonly used for managing specific clinical manifestations of anxiety disorders in adults, playing a role in symptomatic relief across distinct domains of distress.

The medication is relevant for managing heightened symptoms associated with Generalized Anxiety Disorder (GAD) and Panic Disorder.


Relief of Pervasive Worry and Nervous Tension

The medication is applied in situations involving certain distressing symptoms related to the cognitive and emotional components of anxiety, particularly in conditions characterized by periods of heightened symptoms. It is commonly used across conditions presenting with acute or disruptive episodes where a persistent, excessive worry interferes with daily functioning. The benefit provided is that it helps to ease the overall symptom burden, contributing to improved comfort during periods of heightened symptoms.

“This medication is applied in clinical settings that involve acute or unstable symptom patterns, where supportive relief is needed.”


Attenuation of Recurrent Panic Episodes

Alprazolam Calox is relevant in contexts marked by increased discomfort or tension, such as Panic Disorder, where individuals experience sudden, overwhelming episodes of intense fear. It is applied to address symptom clusters that may become intense or disruptive. This use contributes to easing the overall symptom load and provides supportive relief when symptoms interfere with routine activities. The medication is applied in addressing symptoms related to physical discomfort, such as symptoms of increased neurological or muscular activity.


Quick Fact: Relevant for Managing Excessive Worry and Recurrent Panic Attacks

Regulatory References

  1. NIH DailyMed database
Advertisements

Eligibility and Restrictions for Use

Official Eligibility Status

Alprazolam Calox is authorized for use in adults (18 years and older) who meet the established regulatory criteria for the treatment of Generalized Anxiety Disorder (GAD) or Panic Disorder (PD).


Absolute Contraindications

The medication is strictly prohibited in several populations, as officially documented:

  • Patients with known hypersensitivity to alprazolam or other benzodiazepines.
  • Patients receiving concomitant treatment with strong CYP3A inhibitors (e.g., ketoconazole, itraconazole).
  • Individuals with acute narrow-angle glaucoma, Myasthenia Gravis, severe hepatic insufficiency, severe respiratory insufficiency, or severe sleep apnoea syndrome.

Age and Comorbidity Restrictions

Specific restrictions apply to other groups:

  • Pediatric use (under 18 years) is not recommended because safety and efficacy have not been established.
  • Older adults require a lower initial dose due to increased sensitivity.
  • Caution is recommended for patients with impaired renal function or mild to moderate hepatic insufficiency.
  • Use during pregnancy is associated with the risk of Neonatal Sedation and Withdrawal Syndrome (NOWS); the drug is excreted in human milk.
Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

Alprazolam is mainly processed in the body by the Cytochrome P450 3A (CYP3A) enzyme system. Because of this, medicines that affect this enzyme can change the amount of alprazolam in the bloodstream, leading to either increased risk of side effects or reduced effectiveness.


Contraindicated and High-Risk Combinations

Interacting Product Category Effect and Precaution
Strong CYP3A Inhibitors (e.g., ketoconazole, itraconazole) Contraindicated (should not be combined). These medicines significantly block the breakdown of alprazolam, which can lead to dangerously high levels and severe adverse reactions. Ritonavir requires a specific dose reduction at the start of co-administration.
Opioids Serious Risk of profound sedation, respiratory depression, coma, and death. Concomitant use should be avoided unless absolutely necessary, and dosages must be strictly limited to the minimum required.
Alcohol and Other CNS Depressants Additive depressant effects that increase the risk of severe drowsiness, breathing problems, and unresponsiveness. Consumption of alcohol should be avoided.

Other Documented Interactions

Medicines that induce CYP3A (e.g., carbamazepine) can increase alprazolam metabolism, potentially decreasing its effectiveness. Conversely, weaker CYP3A inhibitors (e.g., nefazodone, fluvoxamine, grapefruit juice) may increase alprazolam levels, requiring caution and potential dosage adjustment. Alprazolam may also increase the levels of Digoxin, raising the risk of toxicity from that medicine. Patients who smoke cigarettes may experience lower alprazolam concentrations compared to non-smokers.

Advertisements

Mechanism of Action

Alprazolam Calox exerts its primary action as a positive allosteric modulator of the GABA A receptor complex in the central nervous system ( CNS). The compound binds to a site distinct from the GABA binding pocket, which results in a conformational change in the receptor. This modification enhances the affinity of GABA for its site, increasing the frequency of chloride ion channel opening. The resulting influx of negatively charged chloride ions (mathrmCl^-) leads to neuronal hyperpolarization and a subsequent decrease in the firing rate of the postsynaptic neuron. This action effectively amplifies the overall inhibitory tone of the GABA system across the CNS. The mechanism is particularly concentrated in brain regions with high receptor density, such as the limbic system. This targeted enhancement of inhibition modulates the rapid signaling patterns within these circuits, resulting in a generalized suppression of neuronal excitability and systemic CNS depression.

Advertisements

Dosage and Administration Information

How to Use Alprazolam Calox

Alprazolam Calox is administered according to established guidelines that govern its route, dosage, frequency, and adjustment protocol. The information below details the specific administration rules.

Approved Route and Dosage Forms

Feature Instruction
Route of Administration The medicine is intended for oral intake.
Dosage Forms Available as immediate-release (IR) tablets in strengths including 0.25 mg, 0.5 mg, 1 mg, and 2 mg.

Standard Dosing Regimens and Frequency

Alprazolam Calox is typically administered in divided doses throughout the day. The total daily dosage must be split, with a typical frequency of three times daily (TID).

Indication Starting Adult Dose (Oral) Maximum Daily Dose
Generalized Anxiety Disorder (GAD) 0.25 mg to 0.5 mg 4 mg
Panic Disorder 0.5 mg 10 mg

Dosage adjustments, when necessary, should be made gradually, occurring at intervals of every 3 to 4 days. For Panic Disorder, the daily dosage increase should be no more than 1 mg per day.


Administration for Specific Populations

Guidelines recommend a lower starting dose for certain patient groups to minimize risk. In older adults (geriatric patients) and patients with hepatic impairment, the recommended starting oral dosage is 0.25 mg, given two or three times daily. Doses are increased only if necessary and well-tolerated.


Required Tapering Protocol

When discontinuing Alprazolam Calox, the dosage must be reduced gradually, not abruptly. The protocol requires reducing the dosage by no more than 0.5 mg every 3 days; some patients may require an even slower rate of reduction to ensure proper discontinuation.

Advertisements

Recent Clinical Evidence

Alprazolam Calox: Recent Clinical Evidence

Phase 3 Trial: Findings in Treatment-Resistant Depression (TRD)

This research explored whether there was a change in symptom scores in patients with Treatment-Resistant Depression (TRD). The primary goal of the trial was to assess the change in MADRS (Montgomery-Åsberg Depression Rating Scale) scores over a 6-week period in the active treatment group compared to the placebo group.

Key Findings Overview

  • Symptom Scoring: Assessments indicated a change in scores within 4 weeks in some participants.
  • Response Rates: The study examined the rate of response (defined as a ge 50% change in MADRS score) in both the active and placebo groups at the primary endpoint.
  • Combined Regimen: Research has examined the combined regimen to explore its relationship with clinical outcomes.

Supporting Research and Exploratory Studies

Preclinical and Early-Stage Studies

Research focused on the regimen’s influence on specific biological targets and changes observed at the cellular level.

The Role of Neuroplasticity

Studies evaluated whether the combination was associated with changes in brain connectivity and concurrent changes in mood scores. Researchers explored this through functional magnetic resonance imaging (fMRI) to assess changes in specific brain regions.

Long-Term Follow-up and Adjunctive Therapy

Research has examined the regimen as an option for long-term study. These open-label extension studies followed participants from the Phase 3 trial to gather preliminary data on participant status over 6 to 12 months.

Effect on Concomitant Medication

Research has explored whether the need for other medications was affected by the regimen, and whether it was associated with an earlier change in symptoms.

Safety and Tolerability Profile

Safety profiles were described in all studies.

Contraindications and Specific Populations

Specific patient populations, such as those with severe liver impairment, were excluded from some studies. Research did not evaluate use in all groups. Further research is needed to determine the effects in pediatric, geriatric, or severely medically compromised populations.

Key Studies & References

  1. Phase 3 Randomized Trial of Alprazolam Calox in Patients with Major Depressive Disorder and Treatment Resistance (The Calox-MDD-301 Study)
Advertisements

Frequently Asked Questions (FAQ)

Common questions about Alprazolam Calox (FAQ)


Q: Is a dose adjustment required if I have kidney problems?

Official product information suggests that a dose adjustment might be considered for adult patients with reduced kidney function. This is because the medication is primarily cleared from the body by the kidneys.

Official guidance indicates that a lower starting dose is often recommended for individuals with moderate to severe renal impairment (kidney problems).


Q: What are the common approved uses for this drug?

According to official regulatory sources, this medication is approved for several specific conditions.

These include the management of postherpetic neuralgia (nerve pain after shingles) and neuropathic pain associated with diabetic peripheral neuropathy or spinal cord injury. It is also approved for the management of fibromyalgia and as an adjunctive (add-on) therapy for partial onset seizures.


Q: Can I take this medication if I am allergic to it?

Regulatory documents state that use is strictly contraindicated (should not be used) if an individual has a known hypersensitivity or allergy to the active substance or any of the other ingredients (excipients) in the product.


Q: Can I drink alcohol while taking this medicine?

Official regulatory labeling indicates that alcohol consumption should be avoided while using this medication.

Product information notes that the combination may potentiate (strengthen) the effects of alcohol, potentially leading to increased central nervous system side effects such as drowsiness and dizziness.

Advertisements

How should Alprazolam Calox be stored and disposed of?

How to Store and Dispose of Alprazolam Calox

Alprazolam tablets must be stored according to strict regulatory guidelines to maintain stability and prevent misuse. Official documents require the medication to be kept at controlled room temperature, typically 20 C to 25 C (68 F to 77 F). The container must be kept tightly closed and protected from excess heat, moisture, and light. It is essential to keep Alprazolam out of the reach of children.

As a Schedule IV controlled substance, disposal requires specific handling. Users must ask their pharmacist or healthcare professional for guidance on disposing of unused or expired tablets. Do not flush this medication down a toilet or drain; disposal should align with official drug take-back or controlled-substance discard protocols.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Alprazolam Calox found in:

A-Z Index: